- Home
- BODI vs UG Comparison
BODI vs UG Comparison
Compare BODI & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- UG
- Stock Information
- Founded
- BODI 1998
- UG 1942
- Country
- BODI United States
- UG United States
- Employees
- BODI N/A
- UG N/A
- Industry
- BODI Industrial Machinery/Components
- UG Package Goods/Cosmetics
- Sector
- BODI Industrials
- UG Consumer Discretionary
- Exchange
- BODI Nasdaq
- UG Nasdaq
- Market Cap
- BODI 46.0M
- UG 50.1M
- IPO Year
- BODI N/A
- UG N/A
- Fundamental
- Price
- BODI $7.94
- UG $10.50
- Analyst Decision
- BODI Strong Buy
- UG
- Analyst Count
- BODI 3
- UG 0
- Target Price
- BODI $12.33
- UG N/A
- AVG Volume (30 Days)
- BODI 11.8K
- UG 8.6K
- Earning Date
- BODI 03-10-2025
- UG 03-21-2025
- Dividend Yield
- BODI N/A
- UG 6.67%
- EPS Growth
- BODI N/A
- UG 38.11
- EPS
- BODI N/A
- UG 0.76
- Revenue
- BODI $451,432,000.00
- UG $12,312,275.00
- Revenue This Year
- BODI N/A
- UG N/A
- Revenue Next Year
- BODI N/A
- UG N/A
- P/E Ratio
- BODI N/A
- UG $13.84
- Revenue Growth
- BODI N/A
- UG 11.51
- 52 Week Low
- BODI $5.14
- UG $7.02
- 52 Week High
- BODI $11.31
- UG $16.25
- Technical
- Relative Strength Index (RSI)
- BODI 62.87
- UG 44.74
- Support Level
- BODI $6.51
- UG $10.31
- Resistance Level
- BODI $8.01
- UG $11.08
- Average True Range (ATR)
- BODI 0.61
- UG 0.38
- MACD
- BODI 0.07
- UG -0.07
- Stochastic Oscillator
- BODI 80.56
- UG 23.85
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in two operating segments, Beachbody and Other.
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.